How to Take Gaviscon: Dosage, Timing, and Safety

Gaviscon works best when taken shortly after eating, because it needs food already in your stomach to form a floating barrier that blocks acid from splashing upward. The timing detail matters more than most people realize: research using radioactive tracers found that taking it on an empty stomach let the product drain out in roughly 20 minutes, while taking it 30 minutes after a meal kept it in place for over three hours. Getting the dose, timing, and form right determines whether Gaviscon actually does its job or passes through without much effect.

Why Timing Around Meals Is So Important

Gaviscon is not a typical antacid. It contains sodium alginate, a seaweed-derived compound that reacts with stomach acid to form a gel-like raft. That raft floats on top of whatever is in your stomach and sits right at the junction between the stomach and the food pipe, physically blocking acid from rising. MRI imaging in healthy volunteers confirmed this: the alginate mass collected at the top of the stomach contents, while a standard liquid antacid simply sank to the bottom.¹

For that raft to form properly, there needs to be a pool of stomach contents for it to float on. A study tracking radiolabeled Gaviscon found that when subjects took it while fasting, half the dose left the stomach in about 22 minutes. When they took it 30 minutes after eating, the half-emptying time stretched to over three hours. And when subjects took it immediately before a meal, the incoming food pushed the Gaviscon down and out, preventing it from floating at all.² The practical upshot: take Gaviscon after you eat, not before, and not on a completely empty stomach unless you are using it for bedtime symptoms.

Standard Dosing

Gaviscon products vary by country and formulation, but the general pattern is similar. For the liquid forms most commonly sold, the typical adult dose is 10 to 20 mL taken after meals and at bedtime. A 20 mL dose of Gaviscon Double Action Liquid, for instance, contains about 1,000 mg of sodium alginate along with sodium bicarbonate and calcium carbonate.³ Chewable tablets are also available and work on the same principle, though the liquid forms tend to produce a more consistent raft.

Most product labels recommend up to four doses per day: after breakfast, after lunch, after dinner, and at bedtime. Do not exceed the maximum daily dose listed on your specific product’s packaging, because the exact formulation and ingredient amounts differ between countries and product lines. In the UK, Gaviscon Advance has a different concentration of alginate than Gaviscon Original, and both differ from what is sold under the Gaviscon name in the United States. Read your label rather than assuming all Gaviscon products are interchangeable.

What Happens Once You Take It

Within minutes of reaching stomach acid, the alginate starts to gel. The bicarbonate in the formula generates carbon dioxide bubbles, which get trapped in the gel and make it buoyant. The result is a foamy raft that rises to the top of your stomach contents. In patients with gastroesophageal reflux, that raft sits right where it matters most: at the junction between the stomach and the esophagus, where a pocket of highly acidic fluid tends to collect after meals.⁴

The raft does two things at once. It acts as a physical barrier, so when your stomach contracts, the raft gets pushed up into the esophagus instead of acid. And the antacid ingredients neutralize some acid on contact. Testing in healthy subjects showed that the percentage of time stomach pH stayed above 4 (a level considered safe for the esophageal lining) was roughly 47 to 51 percent in the 30 minutes after taking Gaviscon Double Action, compared to about 4 percent with a placebo.⁵ That difference is meaningful if you are the person lying awake with a burning throat after dinner.

Bedtime Dosing and Nighttime Reflux

Nighttime reflux is a particular problem because you are lying flat, gravity is no longer helping keep acid in your stomach, and you swallow less often during sleep. Many people find their worst symptoms happen at night. Gaviscon taken at bedtime, even without a preceding meal, can still help because there is usually residual food in the stomach from dinner. An evidence-based consensus on reflux management notes that elevating the head of the bed also reduces esophageal acid exposure overnight and can be combined with alginate therapy.⁶

A randomized trial specifically looked at Gaviscon Advance in people who ate a late-night supper (a common reflux trigger). Compared to a standard antacid, the alginate formula significantly reduced both the time acid was present in the esophagus and the frequency of symptoms the following day.⁷ If you eat late, taking a dose after that meal rather than waiting until you climb into bed is the better strategy, since the raft needs stomach contents to float on.

How It Compares to Proton Pump Inhibitors

Proton pump inhibitors like omeprazole are the standard treatment for frequent or erosive reflux because they shut down acid production at the source. Gaviscon works through an entirely different mechanism: it does not reduce acid secretion at all. Instead, it physically blocks reflux. This distinction has practical consequences worth understanding.

A head-to-head trial comparing Gaviscon to omeprazole in patients with moderate reflux symptoms found that the average time to the first heartburn-free 24-hour period was about two days for both treatments, with no meaningful difference between them.⁸ That result surprised some researchers, because PPIs are generally considered more powerful. But for people with moderate symptoms (not severe erosive disease), the physical barrier approach held its own. This does not mean Gaviscon replaces PPIs in all cases. For severe reflux with esophageal damage, PPIs remain the first-line therapy. But for occasional or moderate heartburn, Gaviscon can be a reasonable alternative that avoids the acid-suppression pathway altogether.

Because Gaviscon does not interfere with acid-producing cells, it also avoids the rebound effect that can happen when you stop a PPI. Some people who discontinue PPIs after weeks of use experience a temporary surge in acid production. Alginates do not trigger this rebound, which is why they are sometimes used as a bridge therapy when patients are being weaned off PPIs or when doctors need to stop acid-suppressing medication before a diagnostic test.⁹

Drug Interactions and Spacing

Gaviscon contains calcium and sometimes aluminum or magnesium salts, depending on the formulation. These minerals can bind to certain medications in the gut and prevent them from being absorbed properly. The two most commonly affected drug classes are fluoroquinolone antibiotics and thyroid hormones.

With fluoroquinolones like ciprofloxacin and norfloxacin, the metal ions in antacid-type products form complexes with the drug molecule. In animal pharmacokinetic studies, co-administration of calcium, magnesium, or aluminum salts with norfloxacin reduced peak blood levels of the antibiotic by anywhere from 29 to 85 percent.¹⁰ That is potentially the difference between an effective antibiotic dose and a dose that does not clear the infection. If you are prescribed a fluoroquinolone, take it at least two hours before or after any Gaviscon dose.

Levothyroxine (thyroid replacement hormone) faces a similar problem. A systematic review of substances that interfere with levothyroxine absorption found that antacids and alginates can bind the drug or alter gut pH enough to reduce uptake. The review noted that separating doses and, in some cases, switching to liquid levothyroxine formulations could eliminate the interaction.¹¹ The standard advice is to take levothyroxine on an empty stomach at least 30 to 60 minutes before eating and to avoid antacids or alginates for at least four hours afterward.

Iron supplements and tetracycline antibiotics can also be affected, though those interactions are better documented with traditional antacids than with alginate formulations specifically. As a general rule, if you take any prescription medication regularly, leave a gap of at least two hours between that medication and a Gaviscon dose. Your pharmacist can tell you whether a wider gap is needed for your specific drug.

Gaviscon During Pregnancy

Heartburn during pregnancy is extremely common, especially in the second and third trimesters, because rising hormone levels relax the muscle at the top of the stomach while the growing uterus pushes stomach contents upward. Many pregnant women look for something safe they can take, and Gaviscon has a solid track record here.

A prospective study of 150 pregnant women with heartburn found that liquid Gaviscon was rated as effective by about 91 percent of investigators and 90 percent of patients, with very few adverse events related to the medication.¹² Serum sodium levels, a concern with sodium-containing products, stayed unchanged throughout the study. A separate trial of Gaviscon Advance in pregnant women found similarly high efficacy ratings, and most participants reported symptom relief within 10 minutes of taking a dose.¹³

Because the alginate component acts locally in the stomach and is not systemically absorbed, it does not cross the placenta in any meaningful way. This makes it one of the preferred first-line options for reflux in pregnancy. That said, pregnant women should still stick to the recommended dose and check the specific product’s sodium content, since some formulations contain more sodium than others, and high sodium intake during pregnancy can worsen fluid retention and blood pressure issues.

Using Gaviscon in Infants and Children

A specialized product called Gaviscon Infant is marketed in some countries for babies with gastroesophageal reflux. It works on the same alginate principle but is reformulated for mixing into feeds. The formulation has evolved over the years; earlier versions contained aluminum, but the current version is aluminum-free.

A Cochrane review of medicines for children with reflux found moderate evidence that Gaviscon Infant improves symptoms, including in babies with functional reflux (meaning reflux without an underlying anatomical or inflammatory cause). However, the reviewers noted that the diversity of study designs made it impossible to pool the results into a single statistical analysis. No serious side effects were reported across the studies reviewed.¹⁴ Additional in vitro and clinical studies have shown that the product reduces the height acid reaches in the esophagus and decreases the number of visible regurgitation episodes.¹⁵

Gaviscon Infant is typically added to bottle feeds or, for breastfed babies, mixed with a small amount of cooled boiled water and given by spoon or syringe after feeding. Dosing depends on the baby’s weight, and a healthcare provider should guide this. It is not the same product as adult Gaviscon, and the two should never be substituted for each other.

Long-Term Use and Overconsumption Risks

Gaviscon is generally considered safe for occasional and short-term use. The alginate itself is inert and passes through the digestive system without being absorbed. The risks come from the antacid ingredients, particularly when someone takes far more than recommended over a long period.

Calcium carbonate, which is in many Gaviscon formulations, can cause a condition called milk-alkali syndrome if consumed in very large quantities over time. A case report described a patient who developed dangerously high blood calcium levels and acute pancreatitis after chronic, excessive self-medication with calcium-rich antacid tablets.¹⁶ This is not something that happens at normal doses, but it illustrates why “more is better” thinking can be dangerous with any antacid product. If you find yourself needing Gaviscon more than a few times a week for more than two weeks, that is a signal to see a doctor rather than to keep increasing the dose.

Some formulations contain meaningful amounts of sodium, which can be a concern for people on sodium-restricted diets due to high blood pressure, heart failure, or kidney disease. Check the sodium content per dose on your specific product’s label. Low-sodium versions exist in some markets.

Persistent Throat Symptoms and Ongoing Research

Beyond classic heartburn, some people experience persistent throat symptoms that may be related to reflux: chronic throat clearing, a sensation of something stuck in the throat, hoarseness, or a nagging cough. The connection between these symptoms and acid reflux is debated among specialists, and standard acid-suppressing drugs have had mixed results in treating them.

There is active interest in whether alginates might help. A large pragmatic trial is currently recruiting 250 adults with persistent throat symptoms to test liquid alginate (Gaviscon Advance) against placebo over eight weeks, using a validated symptom questionnaire as the primary outcome measure.¹⁷ Until results from trials like this are available, using Gaviscon for throat symptoms remains something of a clinical gamble. It is unlikely to do harm at standard doses, but whether it will actually resolve the symptoms is an open question. If you have been clearing your throat for months and an over-the-counter antacid has not fixed it, an ear-nose-and-throat evaluation is a better next step than simply taking more Gaviscon.